Biotech · Private company
Trius Therapeutics LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Track this companyFree. Adds Trius Therapeutics LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) to your Dealase workspace and tells you when its record changes.
Clinical trials40 recruiting or active
Pipeline programs7From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline7
- TR-701 200 mgPhase 2 · Skin Diseases, InfectiousClinicalTrials.gov · fetched Nov 12, 2026
- TR-701 300 mgPhase 2 · Skin Diseases, InfectiousClinicalTrials.gov · fetched Nov 12, 2026
- TR-701 400 mgPhase 2 · Skin Diseases, InfectiousClinicalTrials.gov · fetched Nov 12, 2026
- Human ADMEPhase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
- TR-700 (active moiety)Phase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
- TR-701 (pro-drug)Phase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
- TR-701 FAPhase 1 · Bacterial InfectionClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- Pulmonary Disposition of TR-700 Following Once-Daily Oral 200 mgPHASE1 · COMPLETED · started Dec 8, 2010ClinicalTrials.gov NCT01271998 · fetched Nov 12, 2026
- Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male SubjectsPHASE1 · COMPLETED · started Sep 9, 2010ClinicalTrials.gov NCT01442831 · fetched Nov 12, 2026
- Phase 2 Study of TR-701 in Patients With Complicated Skin and Skin Structure InfectionsPHASE2 · COMPLETED · started Sep 17, 2008ClinicalTrials.gov NCT00761215 · fetched Nov 12, 2026
- Microdialysis and Pharmacokinetic Study of TR-701PHASE1 · COMPLETED · started Apr 4, 2008ClinicalTrials.gov NCT00666601 · fetched Nov 12, 2026